1
As Professor Ro ¨ssner’s eloquent editorial demonstrates, obesity is fast becoming a major global pandemic with lethal consequences. While we may view this as a preventative, public health problem, as members of the worldwide diabetes care team the implications of this, as a source of an ever-increasing supply of diabetic patients, on our ability to provide adequate care are clear. In the next few issues of Practical Diabetes International we are going to publish a number of articles on obesity in an attempt to awaken our readers’ interest. In this issue John Wilding from Liverpool writes about the causes, and Jonathan Webber from Nottingham about the comorbidities of obesity, including diabetes. There will be further articles on the treatment of obesity by diet, drugs and surgery as well as possible arrangements which might be made to treat obesity in the NHS. However there are practical procedures we as individuals could consider: for example, limiting the time spent by our children in front of any screen, computer or TV, to two hours per day, protesting to local councils when they close leisure facilities and to local schools who do not provide domestic science teaching to boys and girls or sell off playing fields for housing because the government tells them to balance their books. However as Professor Ro ¨ssner points out there does appear to be something of a sea change in attitudes to overweight and obesity with more articles in newspapers, on radio and television. While governments are always The king of Tonga in the Pacific recently became one of the most successful members of the Australian Gutbuster program. Two things were remarkable about his success: (1) he lost about 100 kg from a starting point of about 226 kg and (2) this at an age of 86! Success stories of this kind are much needed these days, since we have now reached a global situation when more people in our world die of overnutrition than starvation. The incidence of obesity and type 2 diabetes is accelerating throughout the world. The WHO consultation on obesity 1 has recently summarised prevalence data for weight development and found an acceleration, not only in the Western part of the world, but also in all other regions. Of particular concern is the fact that the prevalence of obesity is accelerating already in childhood, again also ‘If you think diabetes care has problems. . .’ apprehensive of the costs of the prevention and treatment of long term conditions such as obesity (and, for that matter, diabetes) drug companies have no such apprehensions, particularly when it is rumoured that the two years of the Fen-Fen anti-obesity regime in the US created an eight billion dollar market before it was withdrawn for safety considerations. No such market can be ignored. It does not seem accidental that the drug industry’s interest in obesity has been re-awoken. The next ten years in the field of obesity may well prove to be quite exciting, with an expansion in our understanding of the causes and treatment of the condition, with hopefully a big spin-off for diabetes care. However the scale of the problem is immense. In the UK there may well be three million diabetic patients by 2010 but there are just short of ten million obese patients already and the number is steadily increasing. You may think that diabetes care has problems with caseload: these are minor compared to those involved in the care of obese patients. And so, readers, peruse these articles and cogitate; better still read them while you are eating less and exercising more. John K Wales Editor Practical Diabetes International Pract Diab Int October 2001 Vol. 18 No. 8 Copyright © 2001 John Wiley & Sons, Ltd. 263 LEADERS particularly in Southeast Asia. 1 In countries such as the United States type 2 diabetes associated with early and severe obesity has become almost as common as type 1 diabetes in adolescents. Genes change slowly but this epidemic has exploded over a few decades. Although obesity and type 2 diabetes can to a certain extent be explained by genetic factors, this rapid increase over the last few years indicates that the environment, rather than changes in our genetic make-up, explains the increase. One genetic explanation may still be important to recognise: selective mating, meaning that individuals of similar body size are attracted to each other selectively, remains a possibility, which is actually supported by some studies. 2 Birds of a feather stick together. Obesity and type 2 diabetes

‘If you think diabetes care has problems…’

Embed Size (px)

Citation preview

Page 1: ‘If you think diabetes care has problems…’

As Professor Rossner’s eloquent editorial demonstrates,obesity is fast becoming a major global pandemic withlethal consequences. While we may view this as apreventative, public health problem, as members of theworldwide diabetes care team the implications of this, as asource of an ever-increasing supply of diabetic patients,on our ability to provide adequate care are clear.

In the next few issues of Practical Diabetes Internationalwe are going to publish a number of articles on obesity inan attempt to awaken our readers’ interest. In this issueJohn Wilding from Liverpool writes about the causes, andJonathan Webber from Nottingham about thecomorbidities of obesity, including diabetes. There will befurther articles on the treatment of obesity by diet, drugsand surgery as well as possible arrangements which mightbe made to treat obesity in the NHS. However there arepractical procedures we as individuals could consider: forexample, limiting the time spent by our children in frontof any screen, computer or TV, to two hours per day,protesting to local councils when they close leisurefacilities and to local schools who do not providedomestic science teaching to boys and girls or sell offplaying fields for housing because the government tellsthem to balance their books.

However as Professor Rossner points out there doesappear to be something of a sea change in attitudes tooverweight and obesity with more articles in newspapers,on radio and television. While governments are always

The king of Tonga in the Pacific recently became one ofthe most successful members of the Australian Gutbusterprogram. Two things were remarkable about his success:(1) he lost about 100 kg from a starting point of about226 kg and (2) this at an age of 86! Success stories of thiskind are much needed these days, since we have nowreached a global situation when more people in our worlddie of overnutrition than starvation. The incidence ofobesity and type 2 diabetes is accelerating throughout theworld. The WHO consultation on obesity1 has recentlysummarised prevalence data for weight development andfound an acceleration, not only in the Western part of theworld, but also in all other regions.

Of particular concern is the fact that the prevalence ofobesity is accelerating already in childhood, again also

‘If you think diabetes care has problems. . .’apprehensive of the costs of the prevention and treatmentof long term conditions such as obesity (and, for thatmatter, diabetes) drug companies have no suchapprehensions, particularly when it is rumoured that thetwo years of the Fen-Fen anti-obesity regime in the UScreated an eight billion dollar market before it waswithdrawn for safety considerations. No such market canbe ignored. It does not seem accidental that the drugindustry’s interest in obesity has been re-awoken. Thenext ten years in the field of obesity may well prove to bequite exciting, with an expansion in our understanding ofthe causes and treatment of the condition, with hopefullya big spin-off for diabetes care.

However the scale of the problem is immense. In theUK there may well be three million diabetic patients by2010 but there are just short of ten million obese patientsalready and the number is steadily increasing. You maythink that diabetes care has problems with caseload: theseare minor compared to those involved in the care ofobese patients.

And so, readers, peruse these articles and cogitate;better still read them while you are eating less andexercising more.

John K WalesEditorPractical Diabetes International

Pract Diab Int October 2001 Vol. 18 No. 8 Copyright © 2001 John Wiley & Sons, Ltd. 263

L E A D E R S

03-08-01 14:05:09 PagEdit Publication Rev 14.05 page 263 pdi 0272

particularly in Southeast Asia.1 In countries such as theUnited States type 2 diabetes associated with early andsevere obesity has become almost as common as type 1diabetes in adolescents.

Genes change slowly but this epidemic has explodedover a few decades. Although obesity and type 2 diabetescan to a certain extent be explained by genetic factors,this rapid increase over the last few years indicates thatthe environment, rather than changes in our geneticmake-up, explains the increase. One genetic explanationmay still be important to recognise: selective mating,meaning that individuals of similar body size are attractedto each other selectively, remains a possibility, which isactually supported by some studies.2 Birds of a featherstick together.

Obesity and type 2 diabetes